drugset / Trial / NCT00569855

Intravenous Phenoxybenzamine Use in Pediatric Patients Undergoing Open-Heart Surgery

NCT00569855

NaSingle-groupOpen-labelTreatment

Summary

Cardiopulmonary bypass is done with a machine that does the work of the heart and lungs during open-heart surgery. This study is to determine if intravenous (i.v.) phenoxybenzamine is safe. This drug lowers the blood pressure, making it easier for the cardiopulmonary bypass machine to deliver blood and oxygen to all of the organs and tissues.

Timeline

Start
2001-02
Primary completion
2010-08
Completion
2010-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Phenoxybenzamine Small molecule 0.125 mg/kg Intravenous
Subject Phenoxybenzamine Small molecule 1 mg/kg Intravenous

Indications

No indication recorded.